SCHEMBL121468

SCHEMBL121468

CC1(C)OB(c2cccs2)OC1(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 13/20 0.54
LIPG Q9Y5X9 13/20 0.54
P2RX7 Q99572 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
CA12 O43570 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA14 Q9ULX7 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
MAPK1 P28482 1/20 0.32
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
CTNNB1 P35222 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16760950 0.82 LPL (0.40) LPLLIPGNPC1RAB9ACA1
SCHEMBL28957951 0.81 LPL (0.42) LPLLIPG
SCHEMBL23159086 0.79 LPL (0.38) LPLLIPG
SCHEMBL28006069 0.78 LPL (0.38) LPLLIPG
SCHEMBL45156 0.77 LPL (0.56) LPLLIPGNPC1RAB9AMAPK1
SCHEMBL18965018 0.76 LPL (0.37) LPLLIPG
SCHEMBL28516479 0.76 LPL (0.37) LPLLIPG
SCHEMBL2607184 0.76 LPL (0.55) LPLLIPGNPC1RAB9AMAPK1
SCHEMBL14983477 0.75 FBP1 (0.35) LPLLIPGNPC1RAB9AMAPK1
SCHEMBL13081246 0.74 LPL (0.36) LPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 472 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12224439-B2 Boron-containing chemicals as cathode additives, Si anode additives, electrolyte additives or separator modifiers for Li-ion batteries ENEVATE CORPORATION (US) 2025-02-11 US claimed
US-12076715-B1 Synthesis and characterization of air-stable iron-based catalysts for Suzuki-Miyaura cross-coupling reactions of alkyl halides and aryl boronic esters THE TRUSTEES OF BOSTON COLLEGE (MA) 2024-09-03 US claimed
CN-114773368-B Boron-nitrogen organic small molecule and preparation method and application thereof 青岛大学 2023-08-25 CN claimed
CN-116478127-A Cross-shaped near infrared fluorescent compound and preparation method and application thereof 南方医科大学 2023-07-25 CN claimed
CN-115232145-A AIE type organic photosensitizer and synthetic method and application thereof 象山县第一人民医院医疗健康集团 2022-10-25 CN claimed
WO-2022093717-A1 BORON-CONTAINING CHEMICALS AS CATHODE ADDITIVES, SI ANODE ADDITIVES, ELECTROLYTE ADDITIVES OR SEPARATOR MODIFIERS FOR LI-ION BATTERIES ENEVATE CORPORATION (US) 2022-05-05 WO claimed
US-20220131148-A1 BORON-CONTAINING CHEMICALS AS CATHODE ADDITIVES, SI ANODE ADDITIVES, ELECTROLYTE ADDITIVES OR SEPARATOR MODIFIERS FOR LI-ION BATTERIES ENEVATE CORPORATION 2022-04-28 US claimed
US-20200388885-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH LIPO2F2 SALT-CONTAINING ELECTROLYTE FORMULATIONS ENEVATE CORPORATION 2020-12-10 US claimed
EP-4733302-A1 NOVEL ORGANIC COMPOUND, PHOTODIODE INCLUDING SAME, ELECTRONIC APPARATUS INCLUDING SAME PHOTODIODE SFC Co., Ltd. (KR) 2026-04-29 EP disclosed
CN-120864485-B Method for preparing single-wall carbon nano tube 江苏华永烯科技有限公司 2026-04-17 CN disclosed
US-20260107623-A1 NOVEL ORGANIC COMPOUND, PHOTODIODE INCLUDING SAME, ELECTRONIC APPARATUS INCLUDING SAME PHOTODIODE SFC CO LTD (KR) 2026-04-16 US disclosed
US-12590071-B2 Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2026-03-31 US disclosed
US-20260014261-A1 TARGETED PROTEIN MODIFICATION WEATHERWAX BIOTECHNOLOGIES CORP (US) 2026-01-15 US disclosed
CN-120864485-A Method for preparing single-wall carbon nano tube 江苏华永烯科技有限公司 2025-10-31 CN disclosed
US-20050148775-A1 Process for production of heteroaryl-type boron compounds with iridium catalyst MITSUBISHI RAYON CO., LTD. (JP) 2005-07-07 US disclosed
US-20050038068-A1 Thienopyridones as AMPK activators for the treatment of diabetes and obesity ABBVIE INC. 2005-02-17 US disclosed
EP-1481978-A1 PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST Mitsubishi Rayon Co., Ltd. (JP) 2004-12-01 EP disclosed
US-20040133028-A1 Hydroboronation process COMMONWEALTH SCIENTIFIC 2004-07-08 US disclosed
EP-1127060-B1 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2004-04-07 EP disclosed
US-6680401-B1 BORON COMPOUNDS SUCH AS 4-(METHOXYMETHYL)-1,3,2-DIOXABOROLANE, USED AS COUPLERS OR CHEMICAL INTERMEDIATES FOR DRUGS, PESTICIDES OR IN COMBINATORIAL CHEMISTRY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260107623-A1 NOVEL ORGANIC COMPOUND, PHOTODIODE INCLUDING SAME, ELECTRONIC APPARATUS INCLUDING SAME PHOTODIODE NR2E3, NR1D2, NR1D1 LPL 3165/4885LIPG 4294/4885P2RX7 3270/4885
US-20050148775-A1 Process for production of heteroaryl-type boron compounds with iridium catalyst PIN4, IPO5, HLCS LPL 2994/4885LIPG 4113/4885P2RX7 854/4885
US-12076715-B1 Synthesis and characterization of air-stable iron-based catalysts for Suzuki-Miyaura cross-coupling reactions of alkyl halides and aryl boronic esters NBAS, BLVRB, TFRC LPL 3353/4885LIPG 3117/4885P2RX7 4753/4885
US-20040133028-A1 Hydroboronation process ALKBH3, HPD, HVCN1 LPL 4659/4885LIPG 4522/4885P2RX7 3317/4885
US-20050038068-A1 Thienopyridones as AMPK activators for the treatment of diabetes and obesity PRKAG1, PRKAG3, PRKAG2 LPL 324/4885LIPG 1562/4885P2RX7 732/4885
US-12590071-B2 Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof ABL1, TH, CYP3A43 LPL 4355/4885LIPG 4527/4885P2RX7 2226/4885
US-20260014261-A1 TARGETED PROTEIN MODIFICATION MDM2, TP53, VHL LPL 1793/4885LIPG 2600/4885P2RX7 4327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.